Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol plus drospirenone for cognition in healthy early postmenopausal women
ACTRN12608000201370Phase 4Completed
- Sponsor
- Monash University
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of estradiol and drospirenone (2 arms), sponsored by Monash University. Primary endpoint: Effects on cognition as measured by functional Magnetic Resonance Imaging (fMRI). Started Nov 2008; status: completed.
02
Drugs
estradioldrospirenone
Beyond the preview
Go deeper on ACTRN12608000201370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000201370.